🟢 Nasus Pharma is trading 5% up today amid a broad market rebound

Nasus Pharma is trading at $3.23, up +5.05%, amid a broad market rebound.

• The S&P 500, Nasdaq, and Dow were each up more than 0.5%; improving sentiment followed falling oil prices and hopes for U.S.–Iran diplomacy.
• Maxim Group initiated coverage with a Buy rating and $7 price target on October 30; available reporting does not establish it as the cause of the November 2 move.